Optimizing hyaluronic acid therapy for dry eye disease: a systematic review, meta-analysis, and meta-regression by concentration and comparator type
Abstract
Purpose: To evaluate the clinical efficacy of HA-based eye drops for the treatment of DED, stratified by concentration and comparator type, through a systematic review, meta-analysis, and meta-regression.
Methods: A comprehensive literature search was conducted across PubMed, Web of Science, Scopus, and the Cochrane Library, identifying 39 randomized controlled trials involving 3,469 patients. Outcomes included the OSDI, TBUT, Schirmer's test, and corneal staining. Subgroup analyses compared HA to placebo, inactive lubricants, active compounds, and HA-based combinations. HA concentration groups were analyzed separately (≤0.1%, 0.15-0.18%, 0.2-0.3%). Risk of bias and publication bias were assessed using the Cochrane tool and funnel plots. Certainty of evidence was evaluated using GRADE.
Results: HA-based formulations showed significant improvements in symptoms, especially in the 0.15-0.18% subgroup (MD = -14.23; p < 0.001), with consistent benefits in Schirmer's test. Comparisons with placebo, other lubricants, and active agents showed that HA was associated with greater improvement in patient-reported symptoms (OSDI), while objective signs (TBUT and staining) showed variable and often non-significant results. Monotherapy with HA outperformed HA-based combinations in OSDI. The most consistent efficacy and tolerability were observed in intermediate HA concentrations. No significant publication bias was detected.
Conclusion: HA eye drops, particularly formulations within the…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 3,469 participants or records.
Read the paper
Related studies
- Preliminary Toxicity Analysis of 3DCRT versus IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial
- Adaptive Radiotherapy for Head and Neck Cancer: Initial Clinical Outcomes from a Prospective Trial
- American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology
- Motion Management Strategies and Technical Issues Associated with Stereotactic Body Radiotherapy of Thoracic and Upper Abdominal Tumors: A Review from NRG Oncology
- High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial
- Highly efficient training, refinement, and validation of a knowledge-based plan quality control system for radiotherapy clinical trials
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.